Histology And Cytology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Histology and Cytology Pipeline Market Report Overview

Histology and Cytology consist of reagents and test kits used in tissue and cell typing techniques. Reagents like monoclonal antibodies, polyclonal antibodies, immunomodulators, and tissue typing reagents have been tracked under this category in the report. Apart from reagents flow cytometry reagents are also tracked.

The Histology and Cytology pipeline market research report provides comprehensive information about the Histology and Cytology pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Territories ·        The US

·        China

·        Europe

·        Global

·        Canada

Key Segments ·        Flow Cytometers

·        Cytology

·        Histology

·        Monoclonal Antibodies

Key Regulatory Paths ·        510(k)

·        NMPA

·        Ninsho

Leading Companies ·        Access Vascular Inc

·        Advent Access Pte Ltd

·        AngioDynamics Inc

·        Angiotech Pharmaceuticals Inc

·        Ariste Medical LLC

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Histology and Cytology Pipeline Market Segmentation by Segments

Some of the key segments in the Histology and Cytology market are Flow Cytometers, Cytology, Histology, and Monoclonal Antibodies. As of November 2023, Flow Cytometers has the highest number of pipeline products.

Histology and Cytology Pipeline Market Analysis by Segments, 2023 (%)

Histology and Cytology Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segments Insights into the Histology and Cytology Pipeline Market

Download a Free Report Sample

Histology and Cytology Pipeline Market Segmentation by Territories

Some of the key territories in the Histology and Cytology market are the US, China, Europe, Global, and Canada among others. As of November 2023, the US has the highest number of pipeline products.

Histology and Cytology Pipeline Market Analysis by Territories, 2023 (%)

Histology and Cytology Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Histology and Cytology Pipeline Market

Download a Free Report Sample

Histology and Cytology Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Histology and Cytology pipeline market are 510(k), NMPA, and Ninsho. As of November 2023, 510(k) is the most followed pathway for pipeline products in the market.

Histology and Cytology Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Histology and Cytology Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Histology and Cytology Pipeline Market

Download a Free Report Sample

Histology and Cytology Pipeline Market – Competitive Landscape

Some of the key companies in the Histology and Cytology pipeline market are:

  • Acousys Biodevices Inc
  • Agilent Technologies Inc
  • American Association for the Advancement of Science
  • Amerimmune LLC
  • Applikate Technologies LLC

Agilent Technologies Inc (Agilent): It is a provider of instruments, reagents, software, services, and consumables for comprehensive laboratory workflow. Its product portfolio comprises liquid chromatography systems and components, gas chromatography systems and components, microarray solutions, clinical and diagnostic testing, and automation systems, among others. The company serves biotechnology, pharmaceutical, contract research organizations (CROs) and contract manufacturing organizations (CMOs), chemical and energy, environmental and forensics, food, and other industries. Agilent markets products through a direct sales force, distributors, manufacturers’ representatives, resellers, and e-commerce. It has research and development, and manufacturing facilities in the US, the UK, Denmark, Germany, Italy, Japan, Malaysia, China, Singapore, and Australia. Agilent is headquartered in Santa Clara, California, the US.

Histology and Cytology Pipeline Market Analysis by Companies, 2023

Histology and Cytology Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Histology and Cytology Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Histology and Cytology Pipeline Market Segments Outlook

  • Flow Cytometers
  • Cytology
  • Histology
  • Monoclonal Antibodies

Histology and Cytology Pipeline Market Territories Outlook

  • The US
  • China
  • Europe
  • Global
  • Canada

Histology and Cytology Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • NMPA
  • Ninsho

Scope

This report provides:

  • Extensive coverage of the Histology and Cytology under development.
  • Review details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in pipeline product development and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Histology and Cytology under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Acousys Biodevices Inc
Agilent Technologies Inc
American Association for the Advancement of Science
Amerimmune LLC
Applikate Technologies LLC
Arizona State University
Becton Dickinson and Co
Boston College
Boston University
Cytoastra LLC
Eta Diagnostics Inc
Indiana University
Kinetic River Corp
Microsensor Labs LLC
NanoCellect Biomedical, Inc.
North Carolina State University
Seed Partners Ltd
SpikImm SAS
Standard BioTools Inc
Sysmex Corp
The University of Manchester
TU Dortmund University
Ubiquitin Biotechnology (Zhejiang) Co Ltd
University of Arkansas
University of California
University of California Los Angeles
University of Colorado
University of New Mexico
University of Washington
US Naval Research Laboratory
VeraPulse LLC
Yale University

Table of Contents

1 Table of Contents 3

1.1 List of Tables 7

1.2 List of Figures 10

2 Introduction 11

2.1 Histology And Cytology Overview 11

3 Products under Development 12

3.1 Histology And Cytology – Pipeline Products by Stage of Development 12

3.2 Histology And Cytology – Pipeline Products by Segment 13

3.3 Histology And Cytology – Pipeline Products by Territory 14

3.4 Histology And Cytology – Pipeline Products by Regulatory Path 15

3.5 Histology And Cytology – Pipeline Products by Estimated Approval Date 16

3.6 Histology And Cytology – Ongoing Clinical Trials 17

4 Histology And Cytology – Pipeline Products under Development by Companies 18

4.1 Histology And Cytology Companies – Pipeline Products by Stage of Development 18

4.2 Histology And Cytology – Pipeline Products by Stage of Development 20

5 Histology And Cytology Companies and Product Overview 21

5.1 Acousys Biodevices Inc Company Overview 21

5.1.1 Acousys Biodevices Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.2 Agilent Technologies Inc Company Overview 22

5.2.1 Agilent Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 American Association for the Advancement of Science Company Overview 23

5.3.1 American Association for the Advancement of Science Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 Amerimmune LLC Company Overview 24

5.4.1 Amerimmune LLC Pipeline Products & Ongoing Clinical Trials Overview 24

5.5 Applikate Technologies LLC Company Overview 27

5.5.1 Applikate Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 27

5.6 Arizona State University Company Overview 28

5.6.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 28

5.7 Becton Dickinson and Co Company Overview 29

5.7.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 29

5.8 Boston College Company Overview 30

5.8.1 Boston College Pipeline Products & Ongoing Clinical Trials Overview 30

5.9 Boston University Company Overview 31

5.9.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 31

5.10 Cytoastra LLC Company Overview 32

5.10.1 Cytoastra LLC Pipeline Products & Ongoing Clinical Trials Overview 32

5.11 Eta Diagnostics Inc Company Overview 33

5.11.1 Eta Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.12 Indiana University Company Overview 34

5.12.1 Indiana University Pipeline Products & Ongoing Clinical Trials Overview 34

5.13 Kinetic River Corp Company Overview 35

5.13.1 Kinetic River Corp Pipeline Products & Ongoing Clinical Trials Overview 35

5.14 Microsensor Labs LLC Company Overview 36

5.14.1 Microsensor Labs LLC Pipeline Products & Ongoing Clinical Trials Overview 36

5.15 NanoCellect Biomedical, Inc. Company Overview 37

5.15.1 NanoCellect Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

5.16 North Carolina State University Company Overview 40

5.16.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 40

5.17 Seed Partners Ltd Company Overview 41

5.17.1 Seed Partners Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

5.18 SpikImm SAS Company Overview 42

5.18.1 SpikImm SAS Pipeline Products & Ongoing Clinical Trials Overview 42

5.19 Standard BioTools Inc Company Overview 43

5.19.1 Standard BioTools Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.20 Sysmex Corp Company Overview 45

5.20.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 45

5.21 The University of Manchester Company Overview 47

5.21.1 The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 47

5.22 TU Dortmund University Company Overview 48

5.22.1 TU Dortmund University Pipeline Products & Ongoing Clinical Trials Overview 48

5.23 Ubiquitin Biotechnology (Zhejiang) Co Ltd Company Overview 49

5.23.1 Ubiquitin Biotechnology (Zhejiang) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

5.24 University of Arkansas Company Overview 50

5.24.1 University of Arkansas Pipeline Products & Ongoing Clinical Trials Overview 50

5.25 University of California Company Overview 51

5.25.1 University of California Pipeline Products & Ongoing Clinical Trials Overview 51

5.26 University of California Los Angeles Company Overview 52

5.26.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 52

5.27 University of Colorado Company Overview 53

5.27.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 53

5.28 University of New Mexico Company Overview 54

5.28.1 University of New Mexico Pipeline Products & Ongoing Clinical Trials Overview 54

5.29 University of Washington Company Overview 55

5.29.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 55

5.30 US Naval Research Laboratory Company Overview 56

5.30.1 US Naval Research Laboratory Pipeline Products & Ongoing Clinical Trials Overview 56

5.31 VeraPulse LLC Company Overview 57

5.31.1 VeraPulse LLC Pipeline Products & Ongoing Clinical Trials Overview 57

5.32 Yale University Company Overview 60

5.32.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 60

6 Histology And Cytology- Recent Developments 61

6.1 Nov 13, 2023: Harvard Apparatus Regenerative Technology Reports Third Quarter 2023 Financial Results 61

6.2 Nov 09, 2023: Harvard Apparatus Regenerative Technology Schedules Conference Call and Webcast for Q3 2023 Results 62

6.3 Nov 09, 2023: BeiGene Continues Global Growth with Third Quarter 2023 Financial Results and Business Updates 62

6.4 Oct 31, 2023: GE HealthCare Reports Third Quarter 2023 Financial Results 65

6.5 Oct 20, 2023: BioPorto to Host Third Quarter 2023 Earnings Webcast and Analyst Call 66

6.6 Oct 17, 2023: BD Names Greg Rodetis as Senior Vice President of Investor Relations 67

6.7 Oct 04, 2023: Boston University Names Melissa L. Gilliam 11th President 67

6.8 Sep 20, 2023: Cytek Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe 68

6.9 Sep 14, 2023: Cytek Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry 68

6.10 Sep 07, 2023: Veracyte Names Marie-Claire Taine, Ph.D., as General Manager of Its IVD Business Unit To Advance Global Expansion of the Company’s Tests 69

6.11 Sep 06, 2023: Arne Hauge Joins Bio-Works as Chief Financial Officer 70

6.12 Sep 04, 2023: Grifols names Dr. Jorg Schüttrumpf Chief Scientific Innovation Officer 70

6.13 Aug 31, 2023: Abcam Reports Earnings Results for the Half Year Ended June 30, 2023 71

6.14 Aug 29, 2023: SSY Announces 2023 Interim Results 71

6.15 Aug 29, 2023: Bio-Rad Launches First StarBright Red Dye and Extends Range of Antibody Markers Conjugated to StarBright Dyes to Enhance Multiplex Flow Cytometry and Research Capabilities 73

6.16 Aug 23, 2023: MDxHealth Reports Q2 and Half Year 2023 Results 73

6.17 Aug 23, 2023: BD to Present at Investor Healthcare Conferences 75

6.18 Aug 09, 2023: Harvard Apparatus Regenerative Technology Schedules Conference Call and Webcast for Q2 2023 Results 75

6.19 Aug 02, 2023: BeiGene Accelerates Global Momentum with Strong Second Quarter 2023 Financial Results 76

6.20 Jul 27, 2023: F. Hoffmann-La Roche Announces Half Year Results 2023 78

6.21 Jun 14, 2023: Standard BioTools to Participate in Upcoming Investor Conferences 78

6.22 Jun 08, 2023: Aridis Pharmaceuticals Announces First Quarter 2023 Financial Results and Business Update 78

6.23 Jun 07, 2023: Eckert & Ziegler Strahlen Annual General Meeting Approves Dividend of EUR

0.50 per Share 80

6.24 Jun 01, 2023: Orchard Software, Emerus partner for Point-of-Care testing excellence 80

6.25 May 30, 2023: Abcam announces statement on calling an extraordinary general meeting 81

6.26 May 26, 2023: Novacyt Announces Publication of Annual Report and AGM voting 81

6.27 May 18, 2023: BD launches World’s first spectral cell sorter with high-speed cell imaging 81

6.28 May 18, 2023: Standard BioTools announces NGS Library Preparation as an Upgrade on the X9 High-Throughput Genomics System 82

6.29 May 17, 2023: ABCAM Result of Annual General Meeting 82

6.30 May 17, 2023: Abcam: Statement on potential extraordinary general meeting 83

6.31 May 15, 2023: Standard BioTools Appoints Jeffrey Black as Chief Financial Officer 83

6.32 May 10, 2023: BioPorto announces interim results for the first three months of 2023 84

6.33 May 09, 2023: Grifols delivers strong first quarter financials with 23% revenue growth and an adjusted EBITDA margin above guidance of 21% 85

6.34 May 09, 2023: Standard BioTools reports Q1 2023 financial results 87

6.35 May 09, 2023: GE HealthCare Names James Saccaro Vice President and Chief Financial Officer 88

6.36 May 04, 2023: BeiGene announces unaudited results for the three months ended March 31, 2023 89

6.37 Apr 27, 2023: Veracyte announces five abstracts providing molecular insights into prostate and other cancers to be presented at the 2023 ASCO Annual Meeting 90

6.38 Apr 25, 2023: Standard BioTools announces conference call and webcast for first quarter 2023 financial results 91

6.39 Apr 20, 2023: Cytek Biosciences to report Q1 2023 financial results on May 9, 2023 91

6.40 Apr 20, 2023: QIAGEN announces expansion of supervisory board 92

6.41 Apr 18, 2023: Juntendo University, Sysmex, and ThinkCyte collaborate to advance the early detection and treatment of blood cancer 92

6.42 Apr 10, 2023: Biostage Appoints Ron Packard to Board of Directors 93

6.43 Apr 05, 2023: Notice convening the Annual General Meeting in BioPorto A/S 94

6.44 Mar 30, 2023: Abcam Publication of 2022 Annual Report and Accounts and Notice of Annual General Meeting 98

6.45 Mar 30, 2023: Abcam Publication of 2022 Annual Report and Accounts and Notice of Annual General Meeting 98

6.46 Mar 28, 2023: SSY Group Announces Annual Net Profit $1.123B, Up

42.9%; Final Div 8 Cents 98

6.47 Mar 15, 2023: Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors 98

6.48 Mar 15, 2023: Veracyte Announces Three Abstracts to Be Presented at AACR Annual Meeting 2023 99

6.49 Mar 07, 2023: Cytek Biosciences introduces new 20-Color AML panel 99

6.50 Mar 03, 2023: Grifols Announces Full Year 2022 Earnings 100

6.51 Mar 02, 2023: TeraPore Technologies Raises $10M in Funding 100

6.52 Mar 01, 2023: Biostage Announces Chairman and CEO Transition 100

6.53 Feb 22, 2023: Thomas Glanzmann new Grifols Executive Chairman, after Steven F. Mayer resignation 101

6.54 Feb 22, 2023: MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023 102

6.55 Feb 14, 2023: Standard BioTools Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Business Outlook 102

6.56 Feb 09, 2023: Sysmex Announces Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2023 104

6.57 Feb 08, 2023: Sysmex Corp. Notice of Changes in Representative Directors 106

6.58 Feb 07, 2023: Cytek Biosciences partners with Bio-Rad to expand reagent portfolios 106

6.59 Feb 07, 2023: Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 107

6.60 Feb 07, 2023: QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups 108

6.61 Feb 02, 2023: F. Hoffmann-La Roche Announces Financial Results for fiscal 2022 109

6.62 Jan 31, 2023: Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results 109

6.63 Jan 30, 2023: GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results 109

6.64 Jan 17, 2023: GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023 112

6.65 Jan 10, 2023: GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook 112

6.66 Jan 09, 2023: Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update 113

6.67 Jan 06, 2023: BD Announces Webcast of Annual Meeting of Shareholders 115

6.68 Jan 04, 2023: SSY Group Limited : Voluntary announcement update on business development 115

6.69 Jan 03, 2023: Standard BioTools Announces Appointment of Betsy Jensen as Chief Human Resources Officer 116

6.70 Dec 28, 2022: SSY Group Appointment of Independent Non-executive Director and Change in the Composition of Board Committees 116

6.71 Dec 20, 2022: Eckert & Ziegler Announces Changes in the Supervisory Board 117

6.72 Dec 19, 2022: Eckert & Ziegler Announces Changes in the Management Board 117

6.73 Dec 13, 2022: Thomas Schinecker replaces Severin Schwan as Roche’s new CEO 117

6.74 Dec 08, 2022: BD Releases 2022 Global Inclusion, Diversity and Equity Annual Report 118

6.75 Dec 05, 2022: BioPorto adds Mr. Nis Kruse as EVP of Strategic Partnerships and GM of EMEA & APAC 118

6.76 Nov 21, 2022: Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update 119

7 Appendix 122

7.1 Methodology 122

7.2 About GlobalData 125

7.3 Contact Us 125

7.4 Disclaimer 125

Table

Histology And Cytology – Pipeline Products by Stage of Development 12

Histology And Cytology – Pipeline Products by Segment 13

Histology And Cytology – Pipeline Products by Territory 14

Histology And Cytology – Pipeline Products by Regulatory Path 15

Histology And Cytology – Pipeline Products by Estimated Approval Date 16

Histology And Cytology – Ongoing Clinical Trials 17

Histology And Cytology Companies – Pipeline Products by Stage of Development 18

Histology And Cytology – Pipeline Products by Stage of Development 20

Acousys Biodevices Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Acousys Photoacoustic Flow Cytometer – Product Status 21

Acousys Photoacoustic Flow Cytometer – Product Description 21

Agilent Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 22

Bioenergetic Health Index Test – Product Status 22

Bioenergetic Health Index Test – Product Description 22

American Association for the Advancement of Science Pipeline Products & Ongoing Clinical Trials Overview 23

CytoPAN – Product Status 23

CytoPAN – Product Description 23

Amerimmune LLC Pipeline Products & Ongoing Clinical Trials Overview 24

Dendritic Cell Panel – Product Status 24

Dendritic Cell Panel – Product Description 24

Lymphocyte Division Assay – Product Status 25

Lymphocyte Division Assay – Product Description 25

Neutraphil Oxidative Burst Assay – Product Status 25

Neutraphil Oxidative Burst Assay – Product Description 26

Applikate Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 27

ClearView – Lung Biopsy – Product Status 27

ClearView – Lung Biopsy – Product Description 27

Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 28

nanoFET Probe – Product Status 28

nanoFET Probe – Product Description 28

Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 29

BD ClearCount CD4 Analyzer – Product Status 29

BD ClearCount CD4 Analyzer – Product Description 29

Boston College Pipeline Products & Ongoing Clinical Trials Overview 30

Prognostic Assay – Apoptosis – Product Status 30

Prognostic Assay – Apoptosis – Product Description 30

Boston University Pipeline Products & Ongoing Clinical Trials Overview 31

Parallel Microfluidic Flow Cytometer – Product Status 31

Parallel Microfluidic Flow Cytometer – Product Description 31

Cytoastra LLC Pipeline Products & Ongoing Clinical Trials Overview 32

Photoacoustic Flow Cytometry – Malaria – Product Status 32

Photoacoustic Flow Cytometry – Malaria – Product Description 32

Eta Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Parallel Flow Cytometer – Product Status 33

Parallel Flow Cytometer – Product Description 33

Indiana University Pipeline Products & Ongoing Clinical Trials Overview 34

Ion Channel Probe – Product Status 34

Ion Channel Probe – Product Description 34

Kinetic River Corp Pipeline Products & Ongoing Clinical Trials Overview 35

Label-Free Flow Cytometer – Product Status 35

Label-Free Flow Cytometer – Product Description 35

Microsensor Labs LLC Pipeline Products & Ongoing Clinical Trials Overview 36

Magnetic Cytometer – Product Status 36

Magnetic Cytometer – Product Description 36

NanoCellect Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

3D-FACS – Product Status 37

3D-FACS – Product Description 37

FlowNostic System – Product Status 38

FlowNostic System – Product Description 38

Lab-On-A-Chip Flow Cytometer – COST Coding – Product Status 38

Lab-On-A-Chip Flow Cytometer – COST Coding – Product Description 38

OncoSorter – Product Status 39

OncoSorter – Product Description 39

North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 40

Thermal Flow Cytometer – Product Status 40

Thermal Flow Cytometer – Product Description 40

Seed Partners Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

Flivo Apoptosis Kit – Product Status 41

Flivo Apoptosis Kit – Product Description 41

SpikImm SAS Pipeline Products & Ongoing Clinical Trials Overview 42

COVID-19 – Monoclonal Antibody – Product Status 42

COVID-19 – Monoclonal Antibody – Product Description 42

Standard BioTools Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Helios System – Product Status 43

Helios System – Product Description 44

Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 45

Immuno-flowFISH – Bone Marrow Cancer – Product Status 45

Immuno-flowFISH – Bone Marrow Cancer – Product Description 45

Immuno-flowFISH Test – Leukaemia – Product Status 46

Immuno-flowFISH Test – Leukaemia – Product Description 46

The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 47

Portable Instrument – Urinary Tract Infections – Product Status 47

Portable Instrument – Urinary Tract Infections – Product Description 47

TU Dortmund University Pipeline Products & Ongoing Clinical Trials Overview 48

Envirostat – Product Status 48

Envirostat – Product Description 48

Ubiquitin Biotechnology (Zhejiang) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

Flow Cytometry Device – Product Status 49

Flow Cytometry Device – Product Description 49

University of Arkansas Pipeline Products & Ongoing Clinical Trials Overview 50

Flow Cytometry Tester – Product Status 50

Flow Cytometry Tester – Product Description 50

University of California Pipeline Products & Ongoing Clinical Trials Overview 51

Computation Cytometer – Product Status 51

Computation Cytometer – Product Description 51

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 52

Microfluidic Image Cytometry Device – Product Status 52

Microfluidic Image Cytometry Device – Product Description 52

University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 53

Flow Cytometry Device – Product Status 53

Flow Cytometry Device – Product Description 53

University of New Mexico Pipeline Products & Ongoing Clinical Trials Overview 54

Magnecytometer – Product Status 54

Magnecytometer – Product Description 54

University of Washington Pipeline Products & Ongoing Clinical Trials Overview 55

Dielectrophoresis (DEP) – Based Device – Product Status 55

Dielectrophoresis (DEP) – Based Device – Product Description 55

US Naval Research Laboratory Pipeline Products & Ongoing Clinical Trials Overview 56

Flow Microflow Cytometer – Product Status 56

Flow Microflow Cytometer – Product Description 56

VeraPulse LLC Pipeline Products & Ongoing Clinical Trials Overview 57

Photoacoustic Flow Cytometry Device – Product Status 57

Photoacoustic Flow Cytometry Device – Product Description 57

VeraPulse LLC – Ongoing Clinical Trials Overview 58

Photoacoustic Flow Cytometry Device – In Vivo Detection of Circulating Clots in Patients With Thromboembolism 59

Yale University Pipeline Products & Ongoing Clinical Trials Overview 60

Integrated Imaging System – Product Status 60

Integrated Imaging System – Product Description 60

Glossary 124

Figures

Histology And Cytology – Pipeline Products by Stage of Development 11_x000D_

Histology And Cytology – Pipeline Products by Segment 12_x000D_

Histology And Cytology – Pipeline Products by Territory 13_x000D_

Histology And Cytology – Pipeline Products by Regulatory Path 14_x000D_

Histology And Cytology – Pipeline Products by Estimated Approval Date 15_x000D_

Histology And Cytology – Ongoing Clinical Trials 16_x000D_

Frequently asked questions

Histology And Cytology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Histology And Cytology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Histology And Cytology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Histology And Cytology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.